| abstract |
The invention relates to gestagens, preferably dienogest, chlormadinone acetate or levonorgestrel, used in combination with oestrogens, such as for example ethinyloestradiol, 17 β -oestradiol or oestradiol valerate and one or more pharmaceutically acceptable excipients/carriers, for lactose-free oral contraception. The invention makes it possible to improve the prophylaxis of lactose intolerance in the case of a possible contributing factor, partly because the tests for lactose intolerance are complicated. The invention is also suitable for long-term application. |